Elysium Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.elysiumrx.com
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
Phase 1
Recruiting
- Conditions
- Acute Pain
- Interventions
- Drug: ETR028, ETR029, [ETR028 + ETR029] or HCBT
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Elysium Therapeutics, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT05572190
- Locations
- 🇺🇸
Medpace, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath